US Stock MarketDetailed Quotes

APYX Apyx Medical

Watchlist

1.390
+0.040+2.96%

Close Jul 22 16:00 ET

1.340
-0.050-3.60%

Post 16:06 ET

48.16MMarket Cap-2106P/E (TTM)

Apyx Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-237.11%-6.34M

74.12%-5.25M

51.17%-2.21M

168.96%3.7M

17.37%-4.85M

58.37%-1.88M

-94.09%-20.28M

-2,216.82%-4.53M

-48.68%-5.36M

-17.30%-5.87M

Net income from continuing operations

-114.89%-7.59M

19.02%-18.85M

-58.68%-9.62M

19.33%-4.68M

81.30%-1.02M

40.82%-3.53M

-53.14%-23.28M

-201.74%-6.07M

-36.87%-5.8M

-34.53%-5.45M

Operating gains losses

--20K

642.67%557K

321,400.00%3.21M

24.14%36K

----

56.25%75K

-200.00%-1K

--29K

--21K

Depreciation and amortization

-22.66%157K

-22.25%692K

-24.75%152K

-13.89%186K

-38.87%151K

-9.78%203K

-1.44%890K

-11.79%202K

-7.69%216K

15.96%247K

Other non cash items

276.12%252K

--632K

--222K

--179K

--164K

--67K

----

Change In working capital

-301.92%-315K

206.25%5.54M

637.71%2.25M

524.14%6.45M

-27.33%-3.31M

123.08%156K

-183.07%-5.22M

-346.47%-419K

-79.03%-1.52M

-0.46%-2.6M

-Change in receivables

134.60%1.48M

97.07%3.97M

-1.99%-1.38M

517.37%7M

-229.36%-2.28M

32.63%630K

141.21%2.02M

21.27%-1.36M

145.14%1.13M

231.81%1.76M

-Change in inventory

-84.30%138K

126.20%1.46M

917.31%1.06M

94.65%-133K

87.75%-345K

336.93%879K

-94.75%-5.57M

111.86%104K

-216.96%-2.49M

-240.92%-2.82M

-Change in prepaid assets

-71.91%241K

64.05%-188K

25,600.00%510K

-2,389.29%-641K

23.62%-915K

32.20%858K

-138.60%-523K

-100.15%-2K

-97.54%28K

18.61%-1.2M

-Change in payables and accrued expense

1.76%-2.17M

126.38%301K

147.84%2.07M

211.68%220K

164.47%225K

-54.72%-2.21M

-125.08%-1.14M

-40.00%834K

-115.04%-197K

-133.43%-349K

Cash from discontinued investing activities

Operating cash flow

-237.11%-6.34M

74.12%-5.25M

51.17%-2.21M

168.96%3.7M

17.37%-4.85M

58.37%-1.88M

-94.09%-20.28M

-2,216.82%-4.53M

-48.68%-5.36M

-17.30%-5.87M

Investing cash flow

Cash flow from continuing investing activities

68.18%-35K

766.73%6.73M

34.51%-93K

7.45%-174K

1,873.32%7.11M

60.57%-110K

-39.70%-1.01M

57.23%-142K

-10.59%-188K

-1,282.76%-401K

Net PPE purchase and sale

68.18%-35K

766.73%6.73M

34.51%-93K

7.45%-174K

1,873.32%7.11M

60.57%-110K

-39.70%-1.01M

57.23%-142K

-10.59%-188K

-1,282.76%-401K

Cash from discontinued investing activities

Investing cash flow

68.18%-35K

766.73%6.73M

34.51%-93K

7.45%-174K

1,873.32%7.11M

60.57%-110K

-39.70%-1.01M

57.23%-142K

-10.59%-188K

-1,282.76%-401K

Financing cash flow

Cash flow from continuing financing activities

-100.06%-5K

14,723.04%32.17M

238,540.00%23.84M

29.13%164K

2,200.00%46K

8,177.55%8.11M

804.17%217K

74.36%-10K

484.85%127K

-98.73%2K

Net issuance payments of debt

-100.05%-5K

23,775.00%35.04M

257,920.00%25.78M

56.67%-13K

-1,003.70%-596K

18,370.37%9.87M

37.82%-148K

82.46%-10K

50.82%-30K

-42.11%-54K

Proceeds from stock option exercised by employees

----

-76.44%86K

---586K

-80.89%30K

----

444.78%365K

--0

460.71%157K

--56K

Net other financing activities

----

---2.96M

---1.35M

--147K

--0

---1.75M

----

Cash from discontinued financing activities

Financing cash flow

-100.06%-5K

14,723.04%32.17M

238,540.00%23.84M

29.13%164K

2,200.00%46K

8,177.55%8.11M

804.17%217K

74.36%-10K

484.85%127K

-98.73%2K

Net cash flow

Beginning cash position

328.30%43.65M

-66.98%10.19M

49.22%22.13M

-7.90%18.48M

-38.04%16.26M

-66.98%10.19M

-26.35%30.87M

-51.99%14.83M

-42.13%20.06M

-33.65%26.23M

Current changes in cash

-204.25%-6.38M

259.69%33.65M

560.04%21.54M

167.99%3.69M

136.76%2.31M

230.26%6.12M

-89.03%-21.07M

-2,882.17%-4.68M

-42.36%-5.42M

-28.56%-6.27M

Effect of exchange rate changes

118.97%11K

-148.35%-191K

-151.22%-21K

-116.23%-31K

-181.00%-81K

-192.06%-58K

283.50%395K

-68.22%41K

430.56%191K

1,011.11%100K

End cash Position

129.36%37.28M

328.30%43.65M

49.22%22.13M

-7.90%18.48M

-38.04%16.26M

-66.98%10.19M

-51.99%14.83M

-42.13%20.06M

Free cash flow

-220.24%-6.38M

72.84%-5.78M

50.66%-2.31M

163.48%3.52M

20.17%-5.01M

58.49%-1.99M

-90.57%-21.29M

-3,859.32%-4.67M

-46.97%-5.55M

-24.59%-6.27M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-237.11%-6.34M	74.12%-5.25M	51.17%-2.21M	168.96%3.7M	17.37%-4.85M	58.37%-1.88M	-94.09%-20.28M	-2,216.82%-4.53M	-48.68%-5.36M	-17.30%-5.87M
Net income from continuing operations	-114.89%-7.59M	19.02%-18.85M	-58.68%-9.62M	19.33%-4.68M	81.30%-1.02M	40.82%-3.53M	-53.14%-23.28M	-201.74%-6.07M	-36.87%-5.8M	-34.53%-5.45M
Operating gains losses	--20K	642.67%557K	321,400.00%3.21M	24.14%36K	----	----	56.25%75K	-200.00%-1K	--29K	--21K
Depreciation and amortization	-22.66%157K	-22.25%692K	-24.75%152K	-13.89%186K	-38.87%151K	-9.78%203K	-1.44%890K	-11.79%202K	-7.69%216K	15.96%247K
Other non cash items	276.12%252K	--632K	--222K	--179K	--164K	--67K	----	----	----	----
Change In working capital	-301.92%-315K	206.25%5.54M	637.71%2.25M	524.14%6.45M	-27.33%-3.31M	123.08%156K	-183.07%-5.22M	-346.47%-419K	-79.03%-1.52M	-0.46%-2.6M
-Change in receivables	134.60%1.48M	97.07%3.97M	-1.99%-1.38M	517.37%7M	-229.36%-2.28M	32.63%630K	141.21%2.02M	21.27%-1.36M	145.14%1.13M	231.81%1.76M
-Change in inventory	-84.30%138K	126.20%1.46M	917.31%1.06M	94.65%-133K	87.75%-345K	336.93%879K	-94.75%-5.57M	111.86%104K	-216.96%-2.49M	-240.92%-2.82M
-Change in prepaid assets	-71.91%241K	64.05%-188K	25,600.00%510K	-2,389.29%-641K	23.62%-915K	32.20%858K	-138.60%-523K	-100.15%-2K	-97.54%28K	18.61%-1.2M
-Change in payables and accrued expense	1.76%-2.17M	126.38%301K	147.84%2.07M	211.68%220K	164.47%225K	-54.72%-2.21M	-125.08%-1.14M	-40.00%834K	-115.04%-197K	-133.43%-349K
Cash from discontinued investing activities
Operating cash flow	-237.11%-6.34M	74.12%-5.25M	51.17%-2.21M	168.96%3.7M	17.37%-4.85M	58.37%-1.88M	-94.09%-20.28M	-2,216.82%-4.53M	-48.68%-5.36M	-17.30%-5.87M
Investing cash flow
Cash flow from continuing investing activities	68.18%-35K	766.73%6.73M	34.51%-93K	7.45%-174K	1,873.32%7.11M	60.57%-110K	-39.70%-1.01M	57.23%-142K	-10.59%-188K	-1,282.76%-401K
Net PPE purchase and sale	68.18%-35K	766.73%6.73M	34.51%-93K	7.45%-174K	1,873.32%7.11M	60.57%-110K	-39.70%-1.01M	57.23%-142K	-10.59%-188K	-1,282.76%-401K
Cash from discontinued investing activities
Investing cash flow	68.18%-35K	766.73%6.73M	34.51%-93K	7.45%-174K	1,873.32%7.11M	60.57%-110K	-39.70%-1.01M	57.23%-142K	-10.59%-188K	-1,282.76%-401K
Financing cash flow
Cash flow from continuing financing activities	-100.06%-5K	14,723.04%32.17M	238,540.00%23.84M	29.13%164K	2,200.00%46K	8,177.55%8.11M	804.17%217K	74.36%-10K	484.85%127K	-98.73%2K
Net issuance payments of debt	-100.05%-5K	23,775.00%35.04M	257,920.00%25.78M	56.67%-13K	-1,003.70%-596K	18,370.37%9.87M	37.82%-148K	82.46%-10K	50.82%-30K	-42.11%-54K
Proceeds from stock option exercised by employees	----	-76.44%86K	---586K	-80.89%30K	----	----	444.78%365K	--0	460.71%157K	--56K
Net other financing activities	----	---2.96M	---1.35M	--147K	--0	---1.75M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-100.06%-5K	14,723.04%32.17M	238,540.00%23.84M	29.13%164K	2,200.00%46K	8,177.55%8.11M	804.17%217K	74.36%-10K	484.85%127K	-98.73%2K
Net cash flow
Beginning cash position	328.30%43.65M	-66.98%10.19M	49.22%22.13M	-7.90%18.48M	-38.04%16.26M	-66.98%10.19M	-26.35%30.87M	-51.99%14.83M	-42.13%20.06M	-33.65%26.23M
Current changes in cash	-204.25%-6.38M	259.69%33.65M	560.04%21.54M	167.99%3.69M	136.76%2.31M	230.26%6.12M	-89.03%-21.07M	-2,882.17%-4.68M	-42.36%-5.42M	-28.56%-6.27M
Effect of exchange rate changes	118.97%11K	-148.35%-191K	-151.22%-21K	-116.23%-31K	-181.00%-81K	-192.06%-58K	283.50%395K	-68.22%41K	430.56%191K	1,011.11%100K
End cash Position	129.36%37.28M	328.30%43.65M	328.30%43.65M	49.22%22.13M	-7.90%18.48M	-38.04%16.26M	-66.98%10.19M	-66.98%10.19M	-51.99%14.83M	-42.13%20.06M
Free cash flow	-220.24%-6.38M	72.84%-5.78M	50.66%-2.31M	163.48%3.52M	20.17%-5.01M	58.49%-1.99M	-90.57%-21.29M	-3,859.32%-4.67M	-46.97%-5.55M	-24.59%-6.27M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall